A joint scientific statement outlining venous thromboembolism research priorities

heart attack
Credit: CC0 Public Domain

The International Society on Thrombosis and Haemostasis (ISTH) and the American Heart Association (AHA) have released a joint scientific statement titled, "Venous Thromboembolism Research Priorities," identifying five top priorities for research on venous thromboembolism (VTE), published today in the ISTH journal Research and Practice in Thrombosis and Haemostasis (RPTH) and Circulation, the flagship journal of the American Heart Association. Developed by nine global hematology experts with survey data from 16 scientific organizations, the statement encourages multi-disciplinary approaches to solve important research barriers.

As a leading cause of death and disability, efforts to improve VTE prevention, diagnosis and management are essential to saving lives. To address the challenges in , the joint statement provides a comprehensive guide to future research covering five levels of priorities. These include fundamental research, human research, patient research, practice level research, and community and population research. Examples of identified needs include the development of better pre-clinical models, new diagnostic approaches, risk assessments and treatments, defining the long-term health of VTE patients and evaluating the impact of public awareness campaigns.

"The research priorities detailed in the statement provide a foundation for basic scientists and clinical researchers to transform medical care for patients with VTE and improve outcomes," said the statement's chair, Mary Cushman, M.D., M.Sc. "We hope that researchers, and the public globally will see the need for investing in solutions to address the significant public health impacts of VTE."

VTE is a condition in which a blood clot forms most often in the deep veins of the leg, groin or arm, known as (DVT), breaks free and travels in the circulation, lodging in the lungs, known as pulmonary embolism (PE). It remains a major cause of morbidity and mortality, and affects up to 1 million Americans and 700,000 Europeans every year. Understanding the causes and raising public awareness of VTE could significantly reduce the number of preventable deaths and disabilities associated with the condition.

More information: Mary Cushman et al. Venous Thromboembolism Research Priorities: A Scientific Statement From the American Heart Association and the International Society on Thrombosis and Haemostasis, Circulation (2020). DOI: 10.1161/CIR.0000000000000818

To learn more about RPTH, the official open-access publication of the ISTH, visit rpth.isth.org.

Journal information: Circulation
Citation: A joint scientific statement outlining venous thromboembolism research priorities (2020, July 8) retrieved 20 May 2024 from https://medicalxpress.com/news/2020-07-joint-scientific-statement-outlining-venous.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.

Explore further

American Heart Association issues call to action to prevent venous thromboembolism in hospitalized patients


Feedback to editors